$5.56
0.305.7%
Last update: Nov 6, 4:00 PM
Strata Critical Medical Inc
SRTANASDAQ
Strata Critical Medical (SRTA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Strata Critical Medical (SRTA) last issued guidance on November 3, 2026 for fiscal year 2026. The company guided revenue in the range of $285M - $295M for the period.
Compared to prior guidance, Strata Critical Medical maintained its revenue forecast from a prior range of $285M - $295M.
Strata Critical Medical has issued 6 guidance updates between November 10, 2025 and November 3, 2026. During this period, the company raised its outlook 3 times, reflecting management's growing confidence in business performance.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.04 | $-0.04 | $-0.04 |
| Actual | $-0.09 | $-0.12 | $0.03 | $-0.06 |
| Surprise | -1000.0% | -200.0% | +175.0% | -50.0% |
| Revenue | ||||
| Estimate | $72.8M | $66.9M | $63.7M | $60.4M |
| Actual | $74.1M | $72.5M | $67.4M | $66.8M |
| Surprise | +1.74% | +8.43% | +5.75% | +10.7% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.01 | $0.02 | $0.02 | $0.03 |
| Revenue | ||||
| Consensus | $76.1M | $79.2M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 3, 2026 | $-0.09 | $0.01 | -1000.0 % |
| Q2 | Aug 4, 2026 | $-0.12 | $-0.04 | -200.0 % |
| Q1 | May 6, 2026 | $0.03 | $-0.04 | 175.0 % |
| Q4 | Mar 3, 2026 | $-0.06 | $-0.04 | -50.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 3, 2026 | $74.08M | $72.82M | 1.74 % |
| Q2 | Aug 4, 2026 | $72.51M | $66.87M | 8.43 % |
| Q1 | May 6, 2026 | $67.38M | $63.72M | 5.75 % |
| Q4 | Mar 3, 2026 | $66.79M | $60.35M | 10.7 % |
